![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/CARDIO_Prof.-Bonaca-002-e1599553155767.jpg)
ACC/WCC 2020
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/ACC-225x300.png)
Read the full Report (pdf)
ACC.20/WCC Virtual Meeting American College of Cardiology; 28-30 March 2020
Featured articles
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/CARDIO_Prof.-Bonaca-002-e1599553155767.jpg)
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/08/Medicom-podcast.jpg)
ACC.20/WCC Highlights Podcast Part 1 of 3
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/08/Medicom-podcast.jpg)
ACC.20/WCC Highlights Podcast Part 2 of 3
CONTENTS
Online First
Heart Failure and Cardiomyopathies
Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/Figure-Primary-composite-endpoint-Cardiovascular.png)
Vericiguat shows beneficial effects in a very high-risk HF population
No role for sodium nitrite in out-of-hospital cardiac arrest
Vascular Medicine and Thromboembolism
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/Figure-Cumulative-incidence-of-the-primary-endpoint-versus-time.png)
Rivaroxaban and aspirin effective and safe for PAD patients
Subgroup analysis VOYAGER PAD
TAILOR-PCI misses endpoint but still provides valuable insights
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/Table-Efficacy-outcomes-in-the-intention-to-treat-cohort-1.png)
Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?
Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/Table-Primary-efficacy-outcomes-of-the-CARAVAGGIO-trial-1-1.png)
Apixaban offers new perspective for cancer patients in need of anticoagulation
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Interventional Cardiology
TAVR safe and effective in low-risk bicuspid aortic stenosis patients
TAVR model reveals differences in hospital outcomes
TAVR versus surgery in older patients
Real-world evidence for MitraClip
2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
![](https://conferences.medicom-publishers.com/wp-content/uploads/2020/09/Figure-Primary-analysis-of-blood-pressure-at-3-months-1.png)